BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoon HJ, Cha BS. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 2014; 6(11): 800-811 [PMID: 25429318 DOI: 10.4254/wjh.v6.i11.800] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Freitas I, Boncompagni E, Tarantola E, Gruppi C, Bertone V, Ferrigno A, Milanesi G, Vaccarone R, Tira ME, Vairetti M. In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient Diet. Oxid Med Cell Longev 2016;2016:9307064. [PMID: 26881047 DOI: 10.1155/2016/9307064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ho C, Gao Y, Zheng D, Liu Y, Shan S, Fang B, Zhao Y, Song D, Zhang Y, Li Q. Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway. J Cell Mol Med 2019;23:5108-18. [PMID: 31144451 DOI: 10.1111/jcmm.14380] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
3 Baiceanu A, Mesdom P, Lagouge M, Foufelle F. Endoplasmic reticulum proteostasis in hepatic steatosis. Nat Rev Endocrinol 2016;12:710-22. [PMID: 27516341 DOI: 10.1038/nrendo.2016.124] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 15.8] [Reference Citation Analysis]
4 Han J, Guo X, Meng XJ, Zhang J, Yamaguchi R, Motoo Y, Yamada S. Acupuncture improved lipid metabolism by regulating intestinal absorption in mice. World J Gastroenterol 2020; 26(34): 5118-5129 [PMID: 32982113 DOI: 10.3748/wjg.v26.i34.5118] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee HS, Lee SJ, Ho JN, Cho HY. Preventive Effect of Fermented Chestnut Inner Shell Extract on Obesity-Induced Hepatic Steatosis. Prev Nutr Food Sci 2020;25:32-40. [PMID: 32292753 DOI: 10.3746/pnf.2020.25.1.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Díaz-rúa R, van Schothorst EM, Keijer J, Palou A, Oliver P. Isocaloric high-fat feeding directs hepatic metabolism to handling of nutrient imbalance promoting liver fat deposition. Int J Obes 2016;40:1250-9. [DOI: 10.1038/ijo.2016.47] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Jiang Y, Wu C, Boye A, Wu J, Wang J, Yang X, Yang Y. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation. Mol Cell Biochem 2015;406:255-62. [PMID: 25968067 DOI: 10.1007/s11010-015-2443-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
8 Jiang Y, He Q, Li S, Shi C, Yang X. Reversible severe fatty liver induced by capecitabine: A case report. Medicine (Baltimore) 2017;96:e8547. [PMID: 29145260 DOI: 10.1097/MD.0000000000008547] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Ebrahimi S, Gargari BP, Aliasghari F, Asjodi F, Izadi A. Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease. International Journal for Vitamin and Nutrition Research 2020;90:95-102. [DOI: 10.1024/0300-9831/a000442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Edelman D, Kalia H, Delio M, Alani M, Krishnamurthy K, Abd M, Auton A, Wang T, Wolkoff AW, Morrow BE. Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population. Mol Genet Genomic Med 2015;3:558-69. [PMID: 26740948 DOI: 10.1002/mgg3.168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Han H, Ma H, Rong S, Chen L, Shan Z, Xu J, Zhang Y, Liu L. Flaxseed oil containing flaxseed oil ester of plant sterol attenuates high-fat diet-induced hepatic steatosis in apolipoprotein-E knockout mice. Journal of Functional Foods 2015;13:169-82. [DOI: 10.1016/j.jff.2014.12.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
12 Vanderheiden A, Harrison LB, Warshauer JT, Adams-huet B, Li X, Yuan Q, Hulsey K, Dimitrov I, Yokoo T, Jaster AW, Pinho DF, Pedrosa I, Lenkinski RE, Pop LM, Lingvay I. Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin. The Journal of Clinical Endocrinology & Metabolism 2016;101:1798-806. [DOI: 10.1210/jc.2015-3906] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
13 Xiao J, Bei Y, Liu J, Dimitrova-Shumkovska J, Kuang D, Zhou Q, Li J, Yang Y, Xiang Y, Wang F. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21. J Cell Mol Med. 2016;20:204-216. [PMID: 26648452 DOI: 10.1111/jcmm.12733] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
14 Su Z, Nie Y, Huang X, Zhu Y, Feng B, Tang L, Zheng G. Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns. Front Pharmacol. 2019;10:1193. [PMID: 31649547 DOI: 10.3389/fphar.2019.01193] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
15 Hoang-Yen Tran D, Hoang-Ngoc Tran D, Mattai SA, Sallam T, Ortiz C, Lee EC, Robbins L, Ho S, Lee JE, Fisseha E, Shieh C, Sideri A, Shih DQ, Fleshner P, McGovern DP, Vu M, Hing TC, Bakirtzi K, Cheng M, Su B, Law I, Karagiannides I, Targan SR, Gallo RL, Li Z, Koon HW. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor. Int J Obes (Lond) 2016;40:1424-34. [PMID: 27163748 DOI: 10.1038/ijo.2016.90] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
16 Bahabadi M, Mohammadalipour A, Karimi J, Sheikh N, Solgi G, Goudarzi F, Hashemnia M, Khodadadi I. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. Immunopharmacology and Immunotoxicology 2017;39:233-42. [DOI: 10.1080/08923973.2017.1327965] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
17 Lee H, Lee S, Yu H, Lee J, Cho H. Fermentation with Lactobacillus enhances the preventive effect of garlic extract on high fat diet-induced hepatic steatosis in mice. Journal of Functional Foods 2017;30:125-33. [DOI: 10.1016/j.jff.2016.12.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
18 Liu Q, Liu S, Chen L, Zhao Z, Du S, Dong Q, Xin Y, Xuan S. Role and effective therapeutic target of gut microbiota in NAFLD/NASH. Exp Ther Med 2019;18:1935-44. [PMID: 31410156 DOI: 10.3892/etm.2019.7781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhao M, Xie H, Shan H, Zheng Z, Li G, Li M, Hong L. Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2022;23:1102. [PMID: 35163026 DOI: 10.3390/ijms23031102] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lee YH, Lee SG, Lee CJ, Kim SH, Song YM, Yoon MR, Jeon BH, Lee JH, Lee BW, Kang ES, Lee HC, Cha BS. Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: Animal and human studies. Sci Rep. 2016;6:24013. [PMID: 27045862 DOI: 10.1038/srep24013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
21 Wang T, Yao W, Shao Y, Zheng R, Huang F. PCAF fine-tunes hepatic metabolic syndrome, inflammatory disease, and cancer. J Cell Mol Med 2018;22:5787-800. [PMID: 30216660 DOI: 10.1111/jcmm.13877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
22 Qiu Y, Sui X, Zhan Y, Xu C, Li X, Ning Y, Zhi X, Yin L. Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance. Biochim Biophys Acta Mol Basis Dis 2017;1863:978-90. [PMID: 28153708 DOI: 10.1016/j.bbadis.2017.01.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
23 Xue L, He J, Gao N, Lu X, Li M, Wu X, Liu Z, Jin Y, Liu J, Xu J, Geng Y. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep. 2017;7:45176. [PMID: 28349964 DOI: 10.1038/srep45176] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 19.2] [Reference Citation Analysis]
24 Simões-Alves AC, Costa-Silva JH, Barros-Junior IB, da Silva Filho RC, Vasconcelos DAA, Vidal H, Morio B, Fernandes MP. Saturated Fatty Acid-Enriched Diet-Impaired Mitochondrial Bioenergetics in Liver From Undernourished Rats During Critical Periods of Development. Cells 2019;8:E335. [PMID: 30974751 DOI: 10.3390/cells8040335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Yin K, Zhou X, Jiang W, Wang L, Dai Z, Tang B. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. Dis Markers 2021;2021:9963534. [PMID: 34239622 DOI: 10.1155/2021/9963534] [Reference Citation Analysis]
26 Pereira K, Salsamendi J, Casillas J. The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. J Clin Imaging Sci 2015;5:32. [PMID: 26167390 DOI: 10.4103/2156-7514.157860] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
27 Kim J, Lee DY, Park SE, Park CY, Lee WY, Oh KW, Park SW, Rhee EJ. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLoS One 2017;12:e0180118. [PMID: 28686633 DOI: 10.1371/journal.pone.0180118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
28 Mao L, Zhao T, Song Y, Lin L, Fan X, Cui B, Feng H, Wang X, Yu Q, Zhang J, Jiang K, Wang B, Sun C. The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope? Cell Death Dis 2020;11:518. [PMID: 32647111 DOI: 10.1038/s41419-020-2732-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
29 Guo CH, Chen WL, Liao CH, Huang K, Chen PY, Yang CP. Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice. Int J Med Sci 2018;15:1194-202. [PMID: 30123057 DOI: 10.7150/ijms.26941] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Gu J, Yao M, Yao D, Wang L, Yang X, Yao D. Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation. J Clin Transl Hepatol. 2016;4:123-130. [PMID: 27350942 DOI: 10.14218/jcth.2016.00010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Chi HC, Tsai CY, Tsai MM, Yeh CT, Lin KH. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. J Biomed Sci. 2019;26:24. [PMID: 30849993 DOI: 10.1186/s12929-019-0517-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
32 Hansjosten I, Rapp J, Reiner L, Vatter R, Fritsch-decker S, Peravali R, Palosaari T, Joossens E, Gerloff K, Macko P, Whelan M, Gilliland D, Ojea-jimenez I, Monopoli MP, Rocks L, Garry D, Dawson K, Röttgermann PJF, Murschhauser A, Rädler JO, Tang SVY, Gooden P, Belinga-desaunay MA, Khan AO, Briffa S, Guggenheim E, Papadiamantis A, Lynch I, Valsami-jones E, Diabaté S, Weiss C. Microscopy-based high-throughput assays enable multi-parametric analysis to assess adverse effects of nanomaterials in various cell lines. Arch Toxicol 2018;92:633-49. [DOI: 10.1007/s00204-017-2106-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
33 Fang S, Feng J, Zhang H, Li P, Zhang Y, Zeng Y, Cai Y, Lin X, Xue Y, Guan M. MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice. Adipocyte 2020;9:179-88. [PMID: 32272865 DOI: 10.1080/21623945.2020.1749495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
34 Kargiotis K, Athyros VG, Giouleme O, Katsiki N, Katsiki E, Anagnostis P, Boutari C, Doumas M, Karagiannis A, Mikhailidis DP. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. World J Gastroenterol 2015; 21(25): 7860-7868 [PMID: 26167086 DOI: 10.3748/wjg.v21.i25.7860] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 66] [Article Influence: 11.6] [Reference Citation Analysis]
35 Zhang C, Jia Y, Liu B, Wang G, Zhang Y. TLR4 knockout upregulates the expression of Mfn2 and PGC-1α in a high-fat diet and ischemia-reperfusion mice model of liver injury. Life Sci 2020;254:117762. [PMID: 32437795 DOI: 10.1016/j.lfs.2020.117762] [Reference Citation Analysis]
36 Luo P, Wang PX, Li ZZ, Zhang XJ, Jiang X, Gong J, Qin JJ, Guo J, Zhu X, Yang S, Li H. Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance. Am J Pathol 2016;186:1278-92. [PMID: 26976243 DOI: 10.1016/j.ajpath.2015.12.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
37 Stachowska E, Ryterska K, Maciejewska D, Banaszczak M, Milkiewicz P, Milkiewicz M, Gutowska I, Ossowski P, Kaczorowska M, Jamioł-Milc D, Sabinicz A, Napierała M, Wądołowska L, Raszeja-Wyszomirska J. Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). Int J Mol Sci 2016;17:E1192. [PMID: 27455252 DOI: 10.3390/ijms17071192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
38 Sun X, Duan X, Wang C, Liu Z, Sun P, Huo X, Ma X, Sun H, Liu K, Meng Q. Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice. Eur J Pharmacol 2017;806:75-82. [PMID: 28414056 DOI: 10.1016/j.ejphar.2017.04.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
39 Dorling JL, Ravussin E, Redman LM, Bhapkar M, Huffman KM, Racette SB, Das SK, Apolzan JW, Kraus WE, Höchsmann C, Martin CK; CALERIE Phase 2 Study Group. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. Eur J Nutr 2021;60:1633-43. [PMID: 32803412 DOI: 10.1007/s00394-020-02361-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Hu W, Zhang W, Chen Y, Rana U, Teng RJ, Duan Y, Liu Z, Zhao B, Foeckler J, Weiler H, Kallinger RE, Thomas MJ, Zhang K, Han J, Miao QR. Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway. Hepatology 2016;64:1559-76. [PMID: 27480224 DOI: 10.1002/hep.28747] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
41 Ueno T, Komatsu M. Autophagy in the liver: functions in health and disease. Nat Rev Gastroenterol Hepatol. 2017;14:170-184. [PMID: 28053338 DOI: 10.1038/nrgastro.2016.185] [Cited by in Crossref: 198] [Cited by in F6Publishing: 195] [Article Influence: 39.6] [Reference Citation Analysis]
42 He B, Wu L, Xie W, Shao Y, Jiang J, Zhao Z, Yan M, Chen Z, Cui D. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. BMC Immunol 2017;18:33. [PMID: 28646856 DOI: 10.1186/s12865-017-0215-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
43 Temple JL, Cordero P, Li J, Nguyen V, Oben JA. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence. Int J Mol Sci 2016;17:E947. [PMID: 27314342 DOI: 10.3390/ijms17060947] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 12.8] [Reference Citation Analysis]
44 Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci. 2016;73:1969-1987. [PMID: 26894897 DOI: 10.1007/s00018-016-2161-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 93] [Article Influence: 15.2] [Reference Citation Analysis]
45 Suwarto S, Diahtantri RA, Hidayat MJ, Widjaya B. Nonalcoholic fatty liver disease is associated with increased hemoconcentration, thrombocytopenia, and longer hospital stay in dengue-infected patients with plasma leakage. PLoS One. 2018;13:e0205965. [PMID: 30332476 DOI: 10.1371/journal.pone.0205965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]